NCT05474248

Brief Summary

This is a two-group pretest-posttest, triple-blinded and randomized controlled trial examining the effects of a biofeedback-assisted diaphragmatic breathing training on postpartum anxiety. This study will include full-term postpartum women, aged from 20 to 49, who experienced anxious symptoms with State Anxiety Inventory (A-State) scored 40 or more at the first postpartum day. Participants will be randomly assigned to either an experimental group (n = 64) or a control group (n = 64). The experimental group will undergo the diaphragmatic breathing training assisted with StressEraser to breath slowly 4-6 times per minute and practice 15 minutes twice daily. Participants in the control condition receive postpartum usual care. The outcome measures include anxiety measured by State-Trait Anxiety Inventory (STAI) and the physiological parameters expressed by blood pressure (BP) and heart rate (HR). Measurements will be taken at the first postpartum day and one month postpartum. We except this breathing training design is able to improve women's postpartum anxiety, and in turn improve their physio-psychological health, breastfeeding and baby care skills.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 28, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 12, 2021

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

July 22, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 26, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

July 26, 2022

Status Verified

July 1, 2022

Enrollment Period

1 month

First QC Date

July 22, 2022

Last Update Submit

July 22, 2022

Conditions

Keywords

postpartum anxietybiofeedbackdiaphragmatic breathing

Outcome Measures

Primary Outcomes (2)

  • Postpartum anxiety

    Assessments using the State-Trait Anxiety Inventory-State (STAI-S) for self-reported anxiety symptoms

    Baseline: postpartum day 1-3

  • Postpartum anxiety

    Assessments using the State-Trait Anxiety Inventory-State (STAI-S) for self-reported anxiety symptoms

    Post-test: Change from baseline postpartum anxiety at 4 weeks postpartum

Secondary Outcomes (4)

  • Heart rate

    Baseline: postpartum day 1-3

  • Heart rate

    Post-test: Change from baseline heart rate at 4 weeks postpartum

  • Blood pressure

    Baseline: postpartum day 1-3

  • Blood pressure

    Post-test: Change from baseline heart rate at 4 weeks postpartum

Study Arms (2)

Diaphragmatic Breathing Training

EXPERIMENTAL

The experimental group will undergo the diaphragmatic breathing training assisted with StressEraser to breath slowly 4-6 times per minute and practice 15 minutes twice daily.

Behavioral: Experimental group

Control group

NO INTERVENTION

Usual care

Interventions

Diaphragmatic Breathing Training

Diaphragmatic Breathing Training

Eligibility Criteria

Age20 Years - 49 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • full-term postpartum women
  • aged from 20 to 49
  • STAI-S scored 40 or more at the first postpartum day

You may not qualify if:

  • newborn with severe illness or stillbirth
  • maternal suicide or self-harm
  • drug use: sedatives, hypnotics or antipsychotic drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Tzu Chi Hospital

Taipei, Xindian Dist, 231405, Taiwan

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 22, 2022

First Posted

July 26, 2022

Study Start

February 28, 2021

Primary Completion

April 12, 2021

Study Completion

December 31, 2022

Last Updated

July 26, 2022

Record last verified: 2022-07

Locations